NCT01159067 · OUTCOME
Number of Patients With Serum Ferritin Level Lower Than 1500 ng/mL After Treatment
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- COUNT_OF_PARTICIPANTS
- Unit
- Participants
- Interval / dispersion
- Not reported
- Time frame
- Assessed through 6 months from the start of treatment
What was measured
Number of patients, whose Serum Ferritin levels are lower than 1500 ng/mL at two consecutive study visits. Serum Ferritin levels are measured at screening (baseline), week 4, 8, 12, 16, 20, 24 and end of study.
Groups in this outcome
Arm I
Patients receive oral deferasirox once daily for up to 6 months in the absence of unacceptable toxicity.
| Group | Source count |
|---|---|
| Arm I | 1 |
Reported measurements
Source class 1
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Arm I | 1 | Not reported | Not reported | Not reported | Not reported |
Complete source fields
- classes
- categories
- measurements
- group Id
- OG000
- value
- 1
- denoms
- counts
- group Id
- OG000
- value
- 1
- units
- Participants
- description
- Number of patients, whose Serum Ferritin levels are lower than 1500 ng/mL at two consecutive study visits. Serum Ferritin levels are measured at screening (baseline), week 4, 8, 12, 16, 20, 24 and end of study.
- groups
- description
- Patients receive oral deferasirox once daily for up to 6 months in the absence of unacceptable toxicity.
- id
- OG000
- title
- Arm I
- param Type
- COUNT_OF_PARTICIPANTS
- reporting Status
- POSTED
- time Frame
- Assessed through 6 months from the start of treatment
- title
- Number of Patients With Serum Ferritin Level Lower Than 1500 ng/mL After Treatment
- type
- SECONDARY
- unit Of Measure
- Participants
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle